Malaysia Public Health Expert Calls for Stringent Laws on Flavored E-Cigarettes to Protect Youth

Regulations by 2FIRSTS.ai
Jun.27.2024
Malaysia Public Health Expert Calls for Stringent Laws on Flavored E-Cigarettes to Protect Youth
Malaysia public health expert Prof Dr Sharifa Ezat Wan Puteh urged to ban e-cigarettes, especially those with caffeine.

According to The Sun's report on June 27th, Professor Dr. Sharifa Ezat Wan Puteh, an expert in public health medicine at the National University of Malaysia, recently stated that laws should be enacted to prohibit e-cigarettes, especially those containing caffeine.

 

She suggested legislation to restrict the types and flavors of e-cigarettes, similar to Denmark, Estonia, and Slovenia where only tobacco and mint flavored e-cigarettes can be sold. Alternatively, like Australia, e-cigarettes could only be sold with a prescription and flavors limited to tobacco, mint, and menthol.

 

Izat further stated that currently over 30 countries worldwide have banned the sale of e-cigarettes as consumer products, meaning flavored e-cigarettes are not allowed to be sold.

 

She pointed out that flavored e-cigarettes may attract young people to become interested in them, as the smoking experience is enjoyable and customizable, which could increase the likelihood of them developing a smoking habit.

 

Izat stated that laws should also mandate the disclosure of nicotine concentration and ingredients, and impose strict quality control on e-cigarettes to prevent the addition of highly harmful additives and mixtures, such as delta-9-tetrahydrocannabinol, cannabinol, or synthetic drugs.

 

She also called for strict regulation and publicity of the use of e-cigarettes to deliver compounds such as vitamins.

 

The United States FDA classifies caffeine as a drug and food additive, widely used in various beverages, with a recommended maximum daily intake of 400mg. However, an increasing number of male and female students in Malaysia are becoming dependent on caffeine-containing e-cigarettes, especially coffee-flavored ones, putting them at high risk for health issues.

 

Caffeine is the most commonly used drug in the world, being utilized both as a prescription and over-the-counter medication. It is known for its ability to boost alertness, combat fatigue, and enhance the effects of certain pain medications. When inhaled through smoking, it can produce similar effects to other stimulants, but due to the potential presence of harmful additives such as volatile organic compounds (VOCs), the risks are higher, which can lead to heart disease, palpitations, and insomnia.

 

Some sellers add vitamin E acetate to enhance the flavor, but volatile organic compounds are harmful and may be released from the flavored e-cigarette liquid, especially in coffee-flavored e-cigarette liquids.

 

In addition, Izzat stated that inhaling caffeine through e-cigarettes directly into the lungs may cause irritation, inflammation, and other respiratory issues.

 

High doses of caffeine are concerning because it is a strong stimulant that can increase heart rate and blood pressure. In theory, this could lead to serious cardiovascular issues, such as cardiac arrest. While such high doses may not be obtained from regular e-cigarette use, the risks of illness still need to be a cause for concern.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
STIIIZY Redesign Fails to Escape PAX Labs Patent Import Ban as Section 337 Case Also Involves China ALD
U.S. Customs and Border Protection ruled that STIIIZY had not shown that the redesigned cannabis-vape products covered by its latest request fall outside an ITC limited exclusion order tied to PAX Labs patents. CBP accepted some of STIIIZY’s claim-construction and non-infringement arguments, but the company did not address two additional claims in the same patent. Earlier STIIIZY redesigned cartridges and certain associated components imported with them had received separate CBP clearance.
Sep.16
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Special Report|CrossBar's High-Puff Vapes Draw Attention on Pennsylvania's 163-Product Directory as Link Between Earlier 1.3mL PMTA Filings and New 13mL Products Remains Unclear
Pennsylvania began enforcing its electronic nicotine delivery system directory restrictions on October 19, 2026. Among 163 product listings recorded before enforcement, four CrossBar 20K disposables stood out with 13mL capacity, advertised puff counts of up to 20,000 and a flattened design distinct from conventional pod systems and compact disposables. Historical records identify earlier 1.3mL CrossBar products associated with Romo LLC, while newer 13mL products appeared in several state directories beginning in 2025 under entities including Blue Nine LLC. PMTA compliance expert Mr. K identified amendments and application ownership transfers as possible regulatory mechanisms, although neither has been confirmed in this case. Separately, Reynolds' $7.5 million acquisition of 16 PACHA products and related assets illustrates the commercial value of products linked to historic PMTA submissions.
Special Report
Oct.22
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
FDA Appoints Former Tobacco Enforcement Deputy Jessica Zeller as Director as Agency Weighs PMTA Framework Changes
The U.S. Food and Drug Administration (FDA) has named Jessica Zeller director of the Center for Tobacco Products' (CTP) Office of Compliance and Enforcement (OCE), effective November 1, 2026. Zeller, the office's inaugural deputy director, returns from medical device manufacturer Edwards Lifesciences with more than 20 years of regulatory and legal experience. The appointment follows CTP leadership changes and adjustments to tobacco regulation. Bret Koplow became permanent CTP director in September; the FDA revised enforcement priorities for unauthorized e-cigarettes and nicotine pouches in May and announced faster PMTA review procedures. On September 28, the agency said it would evaluate changes to the existing PMTA regulatory framework, including potential rulemaking to replace it.
FDA
Oct.20 by 2Firsts Perspectives